{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:17:02Z","timestamp":1766269022653},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1153,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1111\/j.1365-2133.2012.10987.x","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T18:28:41Z","timestamp":1334773721000},"page":"348-358","source":"Crossref","is-referenced-by-count":26,"title":["Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells"],"prefix":"10.1093","volume":"167","author":[{"given":"M.","family":"Felcht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Heck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.S.L.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Nashan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Sachse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Booken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Goerdt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-D.","family":"Klemke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,7,5]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification of cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","article-title":"Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification","volume":"143","author":"Senff","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaad.2009.12.062","article-title":"The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinic, histology and immunohistochemistry","volume":"64","author":"Felcht","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<533::AID-PATH473>3.0.CO;2-3","article-title":"Expression of Fas and Fas ligand in cutaneous B-cell lymphoma","volume":"189","author":"Zoi-Toli","year":"1999","journal-title":"J Pathol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/path.2374","article-title":"Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma","volume":"215","author":"van Galen","year":"2008","journal-title":"J Pathol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/jid.2008.430","article-title":"Bcl-xL gene expression correlated with lower apoptotic cell numbers and shorter progression-free survival in PCFCL","volume":"129","author":"Soltani-Arabshahi","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00428-007-0372-0","article-title":"Study of the reactive dendritic cells in small B-cell lymphoproliferations of the skin","volume":"450","author":"Carbonnelle","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.coi.2007.02.004","article-title":"Regulatory T cells and cancer","volume":"19","author":"Wang","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.25429","article-title":"Regulatory T cells in tumor immunity","volume":"127","author":"Nishikawa","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nri2916","article-title":"Phenotypical and functional specialization of FOXP3(+) regulatory T cells","volume":"11","author":"Campbell","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nri2061","article-title":"FOXP3 modifies the phenotypic and functional properties of regulatory T cells","volume":"7","author":"Campbell","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","article-title":"Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse","volume":"24","author":"Bates","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.11618","article-title":"CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression","volume":"98","author":"Sasada","year":"2003","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2741\/s114","article-title":"CD4 (+)CD25(+)Foxp3(+) regulatory T cells and hematological malignancies","volume":"1","author":"Kelley","year":"2010","journal-title":"Front Biosci"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1158\/1078-0432.CCR-04-1869","article-title":"Outcome in Hodgkin\u2019s lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells","volume":"11","author":"Alvaro","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1182\/blood-2008-07-168096","article-title":"Molecular profiling of classical Hodgkin lymphoma tissue uncovers variations in the tumor microenvironment and correlation with EBV infection and outcome","volume":"113","author":"Chetaille","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2006.06.4642","article-title":"Number of CD4+ cells and location of forkhead box protein p3-positive cells in diagnostic follicular lymphoma tissue microarray correlates with outcome","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1200\/JCO.2006.06.4766","article-title":"Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients","volume":"24","author":"Alvaro","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2009-07-235598","article-title":"The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation","volume":"115","author":"Farinha","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/annonc\/mdp056","article-title":"Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK\/T-cell lymphoma","volume":"20","author":"Kim","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.leu.2404182","article-title":"Paucity of FOXP3+ cells in skin and peripheral blood distinguishes S\u00e9zary syndrome from other cutaneous T-cell lymphomas","volume":"20","author":"Klemke","year":"2006","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","article-title":"FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease and survival","volume":"21","author":"Gjerdrum","year":"2007","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1600-0609.2008.01064.x","article-title":"FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations","volume":"80","author":"Gjerdrum","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","article-title":"TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and S\u00e9zary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1038\/jid.2009.175","article-title":"FOXP3+CD25- tumor cells with regulatory function in S\u00e9zary syndrome","volume":"129","author":"Heid","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/BF02505293","article-title":"Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3\/1+3, MS-1+\/-, 25F9-) in psoriatic dermis","volume":"288","author":"Djemadji-Oudjiel","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0065-2776(04)86006-1","article-title":"Interleukin-2, interleukin-15, and their roles in human natural killer cells","volume":"86","author":"Becknell","year":"2005","journal-title":"Adv Immunol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.cell.2007.04.034","article-title":"FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2\/Erb2 oncogene","volume":"129","author":"Zuo","year":"2007","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/leu.2008.224","article-title":"Malignant Tregs express low molecular splice forms of FOXP3 in S\u00e9zary syndrome","volume":"22","author":"Krejsgaard","year":"2008","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4049\/jimmunol.175.1.32","article-title":"In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death","volume":"175","author":"Fritzsching","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1034\/j.1600-0560.2001.028009448.x","article-title":"Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders","volume":"28","author":"Kamarashev","year":"2001","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1172\/JCI200422325","article-title":"Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses","volume":"114","author":"Lim","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.4049\/jimmunol.175.7.4180","article-title":"Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells","volume":"175","author":"Lim","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1182\/blood-2004-03-1214","article-title":"Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation","volume":"104","author":"Xystrakis","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4049\/jimmunol.175.1.246","article-title":"Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity","volume":"175","author":"Bienvenu","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1158\/0008-5472.CAN-06-3304","article-title":"Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer","volume":"67","author":"Hinz","year":"2007","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1479-5876-6-19","article-title":"Foxp3 expression in human cancer cells","volume":"22","author":"Karanikas","year":"2008","journal-title":"J Transl Med"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.3748\/wjg.v16.i43.5502","article-title":"FOXP3 expression and clinical characteristics of hepatocellular carcinoma","volume":"16","author":"Wang","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4110\/in.2010.10.6.247","article-title":"Presence of Foxp3-expressing CD19(+)CD5(+) B cells in human peripheral blood mononuclear cells: human CD19(+)CD5(+)Foxp3(+) regulatory B cell (Breg)","volume":"10","author":"Noh","year":"2010","journal-title":"Immune Netw"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ccr.2009.08.016","article-title":"Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate","volume":"16","author":"Wang","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1111\/j.1365-2133.2012.10987.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1172\/JCI24685","article-title":"The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs","volume":"115","author":"Allan","year":"2005","journal-title":"J Clin Invest"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.10987.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.10987.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T11:32:59Z","timestamp":1713871979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/167\/2\/348\/6614200"}},"subtitle":["FOXP3 in PCBCL"],"short-title":[],"issued":{"date-parts":[[2012,7,5]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10987.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,5]]}}}